Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

  1. Loibl, S.
  2. Loirat, D.
  3. Tolaney, S.M.
  4. Punie, K.
  5. Oliveira, M.
  6. Rugo, H.S.
  7. Bardia, A.
  8. Hurvitz, S.A.
  9. Brufsky, A.M.
  10. Kalinsky, K.
  11. Cortés, J.
  12. O'Shaughnessy, J.A.
  13. Dieras, V.
  14. Carey, L.A.
  15. Gianni, L.
  16. Gharaibeh, M.
  17. Preger, L.
  18. Phan, S.
  19. Chang, L.
  20. Shi, L.
  21. Piccart, M.J.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Any de publicació: 2023

Volum: 178

Pàgines: 23-33

Tipus: Article

DOI: 10.1016/J.EJCA.2022.10.003 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus